ArticleCurrent oncology (Toronto, Ont.)2024

Mogamulizumab and Concomitant Hypofractionated Low-Dose Total Skin Electron Beam Therapy (2 × 4 Gy) in Cutaneous T-Cell Lymphoma: Proof of Principle, Report of Two Cases.

Mathias Oymanns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.